| Ident. | Authors (with country if any) | Title |
|---|
| 002E09 (2015) |
David Lagorce [France] ; Olivier Sperandio [France] ; Jonathan B. Baell [Australie] ; Maria A. Miteva [France] ; Bruno O. Villoutreix [France] | FAF-Drugs3: a web server for compound property calculation and chemical library design |
| 004B88 (2013) |
Hywel D. Williams [Australie] ; Philip Sassene [Danemark] ; Karen Kleberg [Danemark] ; Marilyn Calderone [France] ; Annabel Igonin [France] ; Eduardo Jule [États-Unis] ; Jan Vertommen [France] ; Ross Blundell [France] ; Hassan Benameur [France] ; Anette Müllertz [Danemark] ; Colin W. Pouton [Australie] ; Christopher J. H. Porter [Australie] | Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 3: Understanding Supersaturation Versus Precipitation Potential During the In Vitro Digestion of Type I, II, IIIA, IIIB and IV Lipid-Based Formulations |
| 005135 (2013) |
C. Faivre [France] ; D. Barbolosi [France] ; E. Pasquier [Australie, France] ; N. Andre [France] | A mathematical model for the administration of temozolomide: comparative analysis of conventional and metronomic chemotherapy regimens |
| 005572 (2012) |
Hywel D. Williams [Australie] ; Philip Sassene [Danemark] ; Karen Kleberg [Danemark] ; Jean-Claude Bakala-N'Goma [France] ; Marilyn Calderone [France] ; Vincent Jannin [France] ; Annabel Igonin [France] ; Anette Partheil [Allemagne] ; Delphine Marchaud [France] ; Eduardo Jule [France] ; Jan Vertommen [France] ; Mario Maio [Allemagne] ; Ross Blundell [France] ; Hassan Benameur [France] ; Frédéric Carrière [France] ; Anette Müllertz [Danemark] ; Christopher J. H. Porter [Australie, États-Unis] ; Colin W. Pouton [Australie, États-Unis] | Toward the establishment of standardized in vitro tests for lipid‐based formulations, part 1: Method parameterization and comparison of in vitro digestion profiles across a range of representative formulations |
| 005619 (2012) |
P. Lees [Royaume-Uni] ; R. P. Hunter [États-Unis] ; P. T. Reeves [Australie] ; P. L. Toutain [France] | Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination |
| 005996 (2012) |
François Guilhot [France] ; Timothy P. Hughes [Australie] ; Jorge Cortes [États-Unis] ; Brian J. Druker [États-Unis] ; Michele Baccarani [Italie] ; Insa Gathmann [Suisse] ; Michael Hayes [États-Unis] ; Camille Granvil [États-Unis] ; YANFENG WANG [États-Unis] | Plasma exposure of imatinib and its correlation with clinical response in the Tyrosine Kinase Inhibitor Optimization and Selectivity Trial |
| 005B37 (2012) |
Nicolas Arlicot [France] ; Johnny Vercouillie [France] ; Maria-João Ribeiro [France] ; Clovis Tauber [France] ; Yann Venel [France] ; Jean-Louis Baulieu [France] ; Serge Maia [France] ; Philippe Corcia [France] ; Michael G. Stabin [États-Unis] ; Aaron Reynolds [Australie] ; Michael Kassiou [Australie] ; Denis Guilloteau [France] | Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation |
| 005C00 (2012) |
Didier Lebrec [France] ; Jaime Bosch [Espagne] ; Rajiv Jalan [Royaume-Uni] ; Francis J. Dudley [Australie] ; Rada Jessic [Serbie] ; Richard Moreau [France] ; Juan Carlos Garcia-Pagan [Espagne] ; Rajeshwar P. Mookerjee [Royaume-Uni] ; Eleonora Chiossi [Suisse] ; Paul L. M. Van Giersbergen [Suisse] ; Andjela Kusic-Pajic [Suisse] ; Jasper Dingemanse [Suisse] | Hemodynamics and pharmacokinetics of tezosentan, a dual endothelin receptor antagonist, in patients with cirrhosis |
| 006684 (2011) |
Annelaure Damont [France] ; Raphael Boisgard [France] ; Bertrand Kuhnast [France] ; Frederic Lemee [France] ; Guillaume Raggiri [France] ; Alana M. Scarf [Australie] ; Eleonora Da Pozzo [Italie] ; Silvia Selleri [Italie] ; Claudia Martini [Italie] ; Bertrand Tavitian [France] ; Michael Kassiou [Australie] ; Frederic Dolle [France] | Synthesis of 6-[18F]fluoro-PBR28, a novel radiotracer for imaging the TSPO 18 kDa with PET |
| 006838 (2011) |
Luis G. Paz-Ares [Espagne] ; Carlos Gomez-Roca [France] ; Jean-Pierre Delord [France] ; Andres Cervantes [Espagne] ; Ben Markman [Espagne, Australie] ; Jesus Corral [Espagne] ; Jean-Charles Soria [France] ; Yann Berge [France] ; Desamparados Roda [Espagne] ; Fiona Russell-Yarde [Royaume-Uni] ; Simon Hollingsworth [Royaume-Uni] ; José Baselga [Espagne] ; Pablo Umana [Suisse] ; Luigi Manenti [Suisse] ; Josep Tabernero [Espagne] | Phase I Pharmacokinetic and Pharmacodynamic Dose-Escalation Study of RG7160 (GA201), the First Glycoengineered Monoclonal Antibody Against the Epidermal Growth Factor Receptor, in Patients With Advanced Solid Tumors |
| 007294 (2010) |
Mark A. Rosenthal [Australie] ; Peter Davidson [Nouvelle-Zélande] ; Frederic Rolland [France] ; Mario Campone [France] ; Lingling Xue [États-Unis] ; Tae H. Han [États-Unis] ; Anish Mehta [États-Unis] ; Yuliya Berd [États-Unis] ; Weili He [États-Unis] ; Antonio Lombardi [États-Unis] | Evaluation of the safety, pharmacokinetics and treatment effects of an ανβ3 integrin inhibitor on bone turnover and disease activity in men with hormone‐refractory prostate cancer and bone metastases |
| 007642 (2010) |
Colin J. Jackson [France] ; Colin Scott [Australie] ; Angela Carville [États-Unis] ; Keith Mansfield [États-Unis] ; David L. Ollis [Australie] ; Steven B. Bird [États-Unis] | Pharmacokinetics of OpdA, an organophosphorus hydrolase, in the African green monkey |
| 008828 (2008) |
Jean F. Cuiné [Australie, Suisse] ; Claire L. Mcevoy [Australie] ; William N. Charman [Australie] ; Colin W. Pouton [Australie] ; Glenn A. Edwards [Australie] ; Hassan Benameur [France] ; Christopher J. H. Porter [Australie] | Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self‐emulsifying formulations to dogs |
| 008843 (2008) |
Laurent Besret [France] ; Frédéric Dollé [France] ; Anne-Sophie Hérard [France] ; Martine Guillermier [France] ; Stéphane Demphel [France] ; Françoise Hinnen [France] ; Christine Coulon [France] ; Michèle Ottaviani [France] ; Michel Bottlaender [France] ; Philippe Hantraye [France] ; Michael Kassiou [Australie] | Dopamine D1 receptor imaging in the rodent and primate brain using the isoquinoline (+)‐[11C]A‐69024 and positron emission tomography |
| 009268 (2007) |
S. Modok [Royaume-Uni] ; R. Scott [Royaume-Uni] ; R. A. Alderden [Australie] ; M. D. Hall [Australie] ; H. R. Mellor [Royaume-Uni] ; S. Bohic [France] ; T. Roose [Royaume-Uni] ; T. W. Hambley [Australie] ; R. Callaghan [Royaume-Uni] | Transport kinetics of four-and six-coordinate platinum compounds in the multicell layer tumour model |
| 009923 (2006) |
Pierre J. Ferré [France] ; Kirby Pasloske [Australie] ; Ted Whittem [Australie] ; Millagahamanda G. Ranasinghe [Australie] ; Qiang Li [Australie] ; Hervé P. Lefebvre [France] | Plasma pharmacokinetics of alfaxalone in dogs after an intravenous bolus of Alfaxan‐CD RTU |
| 00A061 (2006) |
Michael Williams [Australie] ; Carine L. A. Saison [France] ; Desmond B. Williams [Australie] ; Rai S. Kookana [Australie] | Can aquatic distribution of human pharmaceuticals be related to pharmacological data? |
| 00A417 (2005) |
Michelle L. James [Australie] ; Roger R. Fulton [Australie] ; David J. Henderson [Australie] ; Stefan Eberl [Australie] ; Steven R. Meikle [Australie] ; Sally Thomson [Australie] ; Robin D. Allan [Australie] ; Frederic Dolle [France] ; Michael J. Fulham [Australie] ; Michael Kassiou [Australie] | Synthesis and in vivo evaluation of a novel peripheral benzodiazepine receptor PET radioligand |
| 00A881 (2004) |
Frédéric Dollé [France] ; Héric Valette [France] ; Stéphane Demphel [France] ; Christine Coulon [France] ; Michelle Ottaviani [France] ; Michel Bottlaender [France] ; Michael Kassiou [Australie] | Radiosynthesis and in vivo evaluation of [11C]Ro‐647312: a novel NR1/2B subtype selective NMDA receptor radioligand |
| 00AB16 (2004) |
G. Roger [France] ; F. Dolle [France] ; B. De Bruin [France] ; X. Liu [Australie] ; L. Besret [France] ; Y. Bramoulle [France] ; C. Coulon [France] ; M. Ottaviani [France] ; M. Bottlaender [France] ; H. Valette [France] ; M. Kassiou [Australie] | Radiosynthesis and pharmacological evaluation of [11C]EMD-95885: a high affinity ligand for NR2B-containing NMDA receptors |
| 00AB62 (2004) |
Fabienne Grellepois [France] ; Fatima Chorki [France] ; Michèle Ourevitch [France] ; Sébastien Charneau [France] ; Philippe Grellier [France] ; Kylie A. Mcintosh [Australie] ; William N. Charman [Australie] ; Bruno Pradines [France] ; Benoit Crousse [France] ; Danièle Bonnet-Delpon [France] ; Jean-Pierre Begue [France] | Orally active antimalarials: Hydrolytically stable derivatives of 10-trifluoromethyl anhydrodihydroartemisinin |
